000 01643 a2200505 4500
005 20250518005758.0
264 0 _c20200320
008 202003s 0 0 eng d
022 _a1468-2079
024 7 _a10.1136/bjophthalmol-2018-313131
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAgarwal, Aniruddha Kishandutt
245 0 0 _aCluster endophthalmitis due to
_h[electronic resource]
260 _bThe British journal of ophthalmology
_c09 2019
300 _a1278-1283 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aEndophthalmitis
_xetiology
650 0 4 _aEye Infections, Bacterial
_xetiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndia
650 0 4 _aIntravitreal Injections
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aStenotrophomonas maltophilia
_xisolation & purification
650 0 4 _aVisual Acuity
700 1 _aAggarwal, Kanika
700 1 _aSamanta, Ramanuj
700 1 _aAngrup, Archana
700 1 _aBiswal, Manisha
700 1 _aRay, Pallab
700 1 _aDogra, Mohit
700 1 _aKatoch, Deeksha
700 1 _aBansal, Reema
700 1 _aSingh, Ramandeep
700 1 _aDogra, Mangat R
700 1 _aGupta, Vishali
773 0 _tThe British journal of ophthalmology
_gvol. 103
_gno. 9
_gp. 1278-1283
856 4 0 _uhttps://doi.org/10.1136/bjophthalmol-2018-313131
_zAvailable from publisher's website
999 _c29036096
_d29036096